Prospective studies of diagnostic test accuracy when disease prevalence is low
- PMID: 12933593
- DOI: 10.1093/biostatistics/3.4.477
Prospective studies of diagnostic test accuracy when disease prevalence is low
Abstract
Prospective studies of diagnostic test accuracy have important advantages over retrospective designs. Yet, when the disease being detected by the diagnostic test(s) has a low prevalence rate, a prospective design can require an enormous sample of patients. We consider two strategies to reduce the costs of prospective studies of binary diagnostic tests: stratification and two-phase sampling. Utilizing neither, one, or both of these strategies provides us with four study design options: (1) the conventional design involving a simple random sample (SRS) of patients from the clinical population; (2) a stratified design where patients from higher-prevalence subpopulations are more heavily sampled; (3) a simple two-phase design using a SRS in the first phase and selection for the second phase based on the test results from the first; and (4) a two-phase design with stratification in the first phase. We describe estimators for sensitivity and specificity and their variances for each design, along with sample size estimation. We offer some recommendations for choosing among the various designs. We illustrate the study designs with two examples.
Similar articles
-
Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.Biometrics. 2004 Jun;60(2):388-97. doi: 10.1111/j.0006-341X.2004.00183.x. Biometrics. 2004. PMID: 15180664
-
Avoiding verification bias in screening test evaluation in resource poor settings: a case study from Zimbabwe.Clin Trials. 2008;5(5):496-503. doi: 10.1177/1740774508096139. Clin Trials. 2008. PMID: 18827042
-
A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.Stat Med. 2006 Oct 30;25(20):3458-73. doi: 10.1002/sim.2451. Stat Med. 2006. PMID: 16374904
-
Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis.J Clin Epidemiol. 2009 Jan;62(1):5-12. doi: 10.1016/j.jclinepi.2008.04.007. Epub 2008 Sep 7. J Clin Epidemiol. 2009. PMID: 18778913 Review.
-
Development of practical recommendations for diagnostic accuracy studies in low-prevalence situations.J Clin Epidemiol. 2019 Oct;114:38-48. doi: 10.1016/j.jclinepi.2019.05.018. Epub 2019 May 28. J Clin Epidemiol. 2019. PMID: 31150837 Review.
Cited by
-
Setting criterion thresholds for estimating prevalence: what is being validated?J Gambl Stud. 2014 Sep;30(3):577-607. doi: 10.1007/s10899-013-9380-y. J Gambl Stud. 2014. PMID: 23526052
-
Serum metabolite biomarkers for the early diagnosis and monitoring of age-related macular degeneration.J Adv Res. 2025 Aug;74:443-454. doi: 10.1016/j.jare.2024.10.001. Epub 2024 Oct 5. J Adv Res. 2025. PMID: 39369956 Free PMC article.
-
Ambulatory Smartwatch ECG Monitoring among Patients Undergoing Transcatheter Aortic Valve Replacement Early after Discharge: An Observational Study.Rev Cardiovasc Med. 2023 Jan 4;24(1):11. doi: 10.31083/j.rcm2401011. eCollection 2023 Jan. Rev Cardiovasc Med. 2023. PMID: 39076857 Free PMC article.
-
A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at risk.EBioMedicine. 2020 Feb;52:102638. doi: 10.1016/j.ebiom.2020.102638. Epub 2020 Jan 31. EBioMedicine. 2020. PMID: 32014820 Free PMC article.
-
Hospital discharge data is not accurate enough to monitor the incidence of postpartum hemorrhage.PLoS One. 2021 Feb 3;16(2):e0246119. doi: 10.1371/journal.pone.0246119. eCollection 2021. PLoS One. 2021. PMID: 33534862 Free PMC article.
LinkOut - more resources
Full Text Sources
Medical